The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Neuronal Matrix Metalloproteinase-9 Is a Determinant of Selective Neurodegeneration
Open accessAbstract
SUMMARY Selective neuronal loss is the hallmark of neurodegenerative diseases. In patients with amyotrophic lateral sclerosis (ALS), most motor neurons die but those innervating extraocular, pelvic sphincter and slow limb muscles exhibit selective resistance. We identified 18 genes that show >10-fold differential expression between resistant and vulnerable motor neurons. One of these, matrix metalloproteinase-9 (MMP-9), is expressed only by fast motor neurons, which are selectively vulnerable. In ALS model mice expressing mutant SOD1, reduction of MMP-9 function using gene ablation, viral gene therapy or pharmacological inhibition significantly delayed muscle denervation. In the presence of mutant SOD1, MMP-9 expressed by fast motor neurons themselves enhances activation of ER stress and is sufficient to trigger axonal die-back. These findings define MMP-9 as a candidate therapeutic target for ALS. The molecular basis of neuronal diversity thus provides novel insights into mechanisms of selective vulnerability to neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1437 · Cited by 1,756
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
From charcot to lou gehrig: deciphering selective motor neuron death in als
Cleveland, D. W., & Rothstein, J. D. (2001) · Nature Reviews Neuroscience · doi:10.1038/35097565 · Cited by 1,389
Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man
Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M., Castellano-Sanchez, A., Khan, J., Polak, M. A., & Glass, J. D. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.10.004 · Cited by 1,357
Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008
Vandooren, J., Van den Steen, P. E., & Opdenakker, G. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.770819 · Cited by 766
Frey, D., Schneider, C., Xu, L., Borg, J., Spooren, W., & Caroni, P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02534.2000 · Cited by 687
Pun, S., Santos, A. F., Saxena, S., Xu, L., & Caroni, P. (2006) · Nature Neuroscience · doi:10.1038/nn1653 · Cited by 658
Saxena, S., & Caroni, P. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.031 · Cited by 572
A role for motoneuron subtype–selective ER stress in disease manifestations of FALS mice
Saxena, S., Cabuy, E., & Caroni, P. (2009) · Nature Neuroscience · doi:10.1038/nn.2297 · Cited by 567
Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory
Nagy, V., Bozdagi, O., Matynia, A., Balcerzyk, M., Okulski, P., Dzwonek, J., Costa, R. M., Silva, A. J., Kaczmarek, L., & Huntley, G. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4359-05.2006 · Cited by 499
Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS
TURNER, B., & TALBOT, K. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.001 · Cited by 496
Motor Neuron Diversity in Development and Disease
Kanning, K. C., Kaplan, A., & Henderson, C. E. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135722 · Cited by 478
Self-citationAlexianu, M. E., Ho, B., Mohamed, A. H., La Bella, V., Smith, R. G., & Appel, S. H. (1994) · Annals of Neurology · doi:10.1002/ana.410360608 · Cited by 375
Hegedus, J., Putman, C. T., & Gordon, T. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.003 · Cited by 321
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
Van Hoecke, A., Schoonaert, L., Lemmens, R., Timmers, M., Staats, K. A., Laird, A. S., Peeters, E., Philips, T., Goris, A., Dubois, B., et al. (2012) · Nature Medicine · doi:10.1038/nm.2901 · Cited by 303
Membrane area and dendritic structure in type‐identified triceps surae alpha motoneurons
Cullheim, S., Fleshman, J. W., Glenn, L. L., & Burke, R. E. (1987) · Journal of Comparative Neurology · doi:10.1002/cne.902550106 · Cited by 289
Saxena, S., Roselli, F., Singh, K., Leptien, K., Julien, J.-P., Gros-Louis, F., & Caroni, P. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.027 · Cited by 275
Gamma and alpha motor neurons distinguished by expression of transcription factor Err3
Friese, A., Kaltschmidt, J. A., Ladle, D. R., Sigrist, M., Jessell, T. M., & Arber, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906809106 · Cited by 235
Hattori, N., Mochizuki, S., Kishi, K., Nakajima, T., Takaishi, H., D'Armiento, J., & Okada, Y. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.081080 · Cited by 231
Mannen, T., Iwata, M., Toyokura, Y., & Nagashima, K. (1977) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.40.5.464 · Cited by 225
Shared Resistance to Aging and ALS in Neuromuscular Junctions of Specific Muscles
Valdez, G., Tapia, J. C., Lichtman, J. W., Fox, M. A., & Sanes, J. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034640 · Cited by 216
Couillard-Després, S., Zhu, Q., Wong, P. C., Price, D. L., Cleveland, D. W., & Julien, J.-P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9626 · Cited by 210
Van den Steen, P. E., Van Aelst, I., Hvidberg, V., Piccard, H., Fiten, P., Jacobsen, C., Moestrup, S. K., Fry, S., Royle, L., Wormald, M. R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512308200 · Cited by 189
Comparison of Adeno-Associated Viral Vector Serotypes for Spinal Cord and Motor Neuron Gene Delivery
Snyder, B. R., Gray, S. J., Quach, E. T., Huang, J. W., Leung, C. H., Samulski, R. J., Boulis, N. M., & Federici, T. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.008 · Cited by 167
Lorenzl, S., Albers, D. S., LeWitt, P. A., Chirichigno, J. W., Hilgenberg, S. L., Cudkowicz, M. E., & Beal, M. F. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00398-2 · Cited by 164
Brockington, A., Ning, K., Heath, P. R., Wood, E., Kirby, J., Fusi, N., Lawrence, N., Wharton, S. B., Ince, P. G., & Shaw, P. J. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1058-5 · Cited by 159
Aronica, E., Catania, M. V., Geurts, J. J. G., Yankaya, B., & Troost, D. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00181-6 · Cited by 155
Towne, C. L., Raoul, C., Schneider, B. L., & Aebischer, P. (2008) · Molecular Therapy · doi:10.1038/mt.2008.73 · Cited by 147
Self-citationShneider, N. A., Brown, M. N., Smith, C., Pickel, J. M., & Álvarez, F. J. (2009) · Neural Development · doi:10.1186/1749-8104-4-42 · Cited by 138
Enjin, A., Bernhardt, N. R., Nakanishi, S. T., Vallstedt, A., Gezelius, H., Memic, F., Lind, M., Hjalt, T. Å. H., Tourtellotte, W. G., Bruder, C. E. G., et al. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22332 · Cited by 137
Kiaei, M., KIPIANI, K., Calingasan, N. Y., Wille, E. J., CHEN, J., Heissig, B., Rafii, S., Lorenzl, S., & Beal, M. F. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.01.036 · Cited by 137
Bories, C., Amendola, J., d’Incamps, B. L., & Durand, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05306.x · Cited by 132
Individual dopamine midbrain neurons: Functional diversity and flexibility in health and disease
Liss, B., & Roeper, J. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.10.004 · Cited by 111
Xia, X., Zhou, H., Huang, Y., & Xu, Z. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.019 · Cited by 104
Hedlund, E., Karlsson, M., Osborn, T. M., Ludwig, W. W., & Ole Isacson, A. (2010) · Brain · doi:10.1093/brain/awq167 · Cited by 98
A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium
Ferrucci, M., Spalloni, A., Bartalucci, A., Cantafora, E., Fulceri, F., Nutini, M., Longone, P., Paparelli, A., & Fornai, F. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.017 · Cited by 94
Avoiding spam in the proteolytic internet: Future strategies for anti-metastatic MMP inhibition
Krüger, A., Kates, R. E., & Edwards, D. R. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.09.016 · Cited by 70
Sparing of the onufrowicz nucleus in sacral anterior horn lesions
Iwata, M., & Hirano, A. (1978) · Annals of Neurology · doi:10.1002/ana.410040309 · Cited by 69
Towne, C. L., Setola, V., Schneider, B. L., & Aebischer, P. (2010) · Molecular Therapy · doi:10.1038/mt.2010.260 · Cited by 63
Self-citationAssociation Studies of MMP-9 in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
He, X., Zhang, L., Yao, X., Hu, J., Yu, L., Jia, H., An, R., Liu, Z., & Xu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073777 · Cited by 59
Chung, C. Y., Licznerski, P., Alavian, K. N., Simeone, A., Lin, Z., Martin, E. R., Vance, J. M., & Ole Isacson, A. (2010) · Brain · doi:10.1093/brain/awq142 · Cited by 59
The matrix metalloproteinases inhibitor Ro 26-2853 extends survival in transgenic ALS mice
Lorenzl, S., Narr, S., Angele, B., Krell, H. W., Gregorio, J., Kiaei, M., Pfister, H.-W., & Beal, M. F. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.026 · Cited by 57
Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis
Dewil, M., Schurmans, C. L., Starckx, S., Opdenakker, G., Bosch, L. V. D., & Robberecht, W. (2005) · Neuroreport · doi:10.1097/00001756-200503150-00003 · Cited by 32
The Gelatinases and Their Inhibitors: The Structure–Activity Relationships
Swarnakar, S., Mishra, A., & Chaudhuri, S. R. (2012) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-0364-9_3 · Cited by 17
Molecular targets for neuroprotection
Przedborski, S. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/1734470410019780 · Cited by 5
Cited by
ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair
Klim, J. R., Williams, L. A., Limone, F., Guerra San Juan, I., Davis-Dusenbery, B. N., Mordes, D. A., Burberry, A., Steinbaugh, M. J., Gamage, K. K., Kirchner, R., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0300-4 · Cited by 653
Tran, N. M., Shekhar, K., Whitney, I. E., Jacobi, A., Benhar, I., Hong, G., Yan, W., Adiconis, X., Arnold, M. E., Lee, J. M., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.11.006 · Cited by 627
The phenotypic variability of amyotrophic lateral sclerosis
Swinnen, B., & Robberecht, W. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.184 · Cited by 603
Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs
Jaiswal, M. K. (2019) · Medicinal Research Reviews · doi:10.1002/med.21528 · Cited by 451
MMP‐9 in translation: from molecule to brain physiology, pathology, and therapy
Vafadari, B., Salamian, A., & Kaczmarek, L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13415 · Cited by 382
Metadata
- Authors
- Kaplan, A., Spiller, K. J., Towne, C., Kanning, K. C., Choe, G. T., Geber, A., Akay, T., Aebischer, P., & Henderson, C. E.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 81
- Issue
- 2
- Pages
- 333-348
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2060230550
- Cited by
- 306
- References
- 46
- FWCI
- 15.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.